BDBM224318 5-(6-{[(1r)-1- cyclobutylethyl]amino}-8- (hexahydrocyclopenta[b][1,4]oxazin- 4(4ah)-yl)-7-[1-(trans-4- methylcyclohexyl)ethyl]-7h-purin-2- yl)-1,3,4-oxadiazol-2(3h)-one (mixture of diastereomers)::US9540377, 18.44

SMILES CC([C@H]1CC[C@H](C)CC1)n1c(N2CCOC3CCCC32)nc2nc(-c3n[nH]c(=O)o3)nc(N[C@H](C)C3CCC3)c21

InChI Key InChIKey=JWRFCMPSRZBFJE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 224318   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 224318BDBM224318(US9540377, 18.44 | 5-(6-{[(1r)-1- cyclobutylethyl]...)
Affinity DataIC50: 5.37nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent